NFKB1 and colonic neoplasm: Curcumin has also been reported to inhibit NF-κB-luciferase HT-29 and in HCT-116 colon cancer cells and to inhibit Wnt/β-catenin pathway in vitro in HCT-116 colon cancer cells and in vivo in mice carrying APC gene mutation.